Semaglutide does not appear to reduce the effectiveness of oral birth control pills based on the pharmacokinetic evidence available. A dedicated drug interaction study found that co-administration with oral semaglutide had no effect on the absorption of the two most common hormones in combination pills. That said, the picture is more nuanced than a simple “no,” because semaglutide can change your body in ways that indirectly affect your risk of unintended pregnancy.
What the Drug Interaction Studies Show
Semaglutide slows gastric emptying, meaning food and medications sit in your stomach longer than usual before moving into your small intestine, where most absorption happens. This raised early concerns that oral birth control pills might not absorb properly while taking semaglutide.
To test this, researchers measured blood levels of ethinylestradiol and levonorgestrel (the two hormones in most combination birth control pills) in women taking oral semaglutide at the same time. Both the total drug exposure over 24 hours and the peak blood concentration were unchanged. The 90% confidence intervals for both hormones fell within the pre-specified “no effect” range, meaning the results were clear enough that researchers could confidently say semaglutide did not interfere with absorption.
The FDA’s prescribing information for Wegovy reflects this finding. While the label notes that semaglutide delays gastric emptying and “has the potential to impact the absorption of concomitantly administered oral medications,” it also states that no clinically relevant drug interactions were observed with ethinylestradiol or levonorgestrel specifically.
Why Regulators Still Urge Caution
In early 2025, the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) issued a reminder that women taking GLP-1 drugs, including semaglutide, should consider using barrier contraception like condoms if they want to avoid pregnancy. This warning applies broadly to the entire class of medications, not just semaglutide specifically.
The concern is stronger for tirzepatide (Mounjaro), which does have evidence suggesting it can reduce oral contraceptive effectiveness. For tirzepatide, the recommendation is to use a backup method or switch to non-oral contraception for four weeks after starting and four weeks after each dose increase. Semaglutide’s interaction data is more reassuring, but regulators have taken a cautious, class-wide approach because all GLP-1 drugs slow gastric emptying to some degree.
The Real Risk: Restored Fertility
The more significant pregnancy risk from semaglutide has nothing to do with how your pill absorbs. It has to do with what weight loss does to your reproductive system.
Many women who take semaglutide have polycystic ovary syndrome (PCOS), irregular cycles, or anovulation linked to higher body weight. Losing even a modest amount of weight can restore regular ovulation, sometimes quickly. In one pilot study of women with PCOS and obesity treated with semaglutide and metformin, 60% achieved pregnancy during the follow-up period. These were women actively trying to conceive, but the finding illustrates how dramatically fertility can bounce back with weight loss.
This is the mechanism behind what social media has dubbed “Ozempic babies.” Women who assumed they had low fertility, perhaps because they hadn’t had regular periods in years, suddenly ovulate again as they lose weight. If they’re relying on birth control they’ve been casual about (missing pills, not refilling on time), they can find themselves pregnant unexpectedly. The Reproductive Health Access Project notes that “pregnancy can occur regardless after starting a GLP-1 agonist,” even in women who weren’t previously ovulating regularly.
Non-Oral Methods Bypass the Concern Entirely
Because the theoretical interaction involves gastric emptying and oral drug absorption, any contraceptive method that doesn’t pass through your digestive system sidesteps the issue completely. Hormonal IUDs, copper IUDs, the implant, and the injectable shot all deliver contraception without involving your stomach or intestines. These methods are also among the most effective forms of birth control overall, with failure rates under 1%.
The vaginal ring and the patch are also non-oral options, though they deliver hormones through the skin or vaginal tissue rather than the gut. If you’re starting semaglutide and want to eliminate any uncertainty about drug interactions, switching to one of these methods is the most straightforward solution.
What to Do If You Stay on the Pill
If you’re taking combination birth control pills and starting semaglutide, the pharmacokinetic data suggests your pill should continue to work normally. The key is consistency. Take your pill at the same time each day, don’t skip doses, and be aware that vomiting or severe diarrhea (both possible side effects of semaglutide, especially during dose escalation) can reduce how much hormone your body absorbs from a pill. If you vomit within a few hours of taking your pill, treat it as a missed dose and follow the instructions in your pill’s packaging.
During dose escalation, when gastrointestinal side effects tend to be at their worst, using condoms as a backup is a reasonable precaution. This isn’t because semaglutide is chemically interfering with your pill. It’s because nausea and vomiting are common during those early weeks, and either one can physically prevent your pill from being absorbed.
Stop Semaglutide Before Trying to Conceive
Semaglutide is not safe during pregnancy. The product labels for Ozempic, Wegovy, and Rybelsus all recommend stopping the medication at least two months before a planned pregnancy. This washout period allows the drug to clear your system, since semaglutide has a long half-life of about a week and takes several weeks to fully leave your body. If you discover you’re pregnant while taking semaglutide, contact your prescriber promptly to discuss next steps.